Export

EN
FR
Liraglutide
Essential medicine status
General description

INN
Liraglutide
ATC codes
A10BJ02
Medicine type
Chemical agent
EML status history
Application rejected in 2023 (TRS 1049) for Obesity
Application rejected in 2025 (TRS 1064) for Obesity
Changed in 2025 (TRS 1064) for Type 2 diabetes mellitus
Therapeutic equivalent for
semaglutide for Obesity, unspecified
semaglutide for Type 2 diabetes mellitus
Wikipedia
Liraglutide
DrugBank
Liraglutide
Recommendations
Section
Medicines for endocrine disorders
  • Parenteral > General injections > SC: 6 mg per mL in 3 mL pre-filled pen
Indications
Obesity